RXO241220P22500
- 0.00
- 0.000.00%
RXO Inc Newsroom
RXO (RXO): Buy, Sell, or Hold Post Q3 Earnings?
RXO Announces Participation at Upcoming Investor Conferences
'Busiest Thanksgiving Ever': How the TSA Plans to Handle Record Air Travel
BofA Securities Maintains RXO Inc(RXO.US) With Hold Rating, Cuts Target Price to $29
Goldman Sachs Maintains RXO Inc(RXO.US) With Hold Rating, Raises Target Price to $29
Express News | RXO Inc : BofA Global Research Cuts Price Objective to $29 From $30
SIG Maintains RXO Inc(RXO.US) With Sell Rating, Cuts Target Price to $12
RXO Shares Are Trading Lower After Citigroup Downgraded the Stock From Buy to Neutral and Maintained the Price Target From $33. Also, Susquehanna Maintained a Negative Rating on the Stock and Lowered Its Price Target From $16 to $12.
RXO Is Maintained at Negative by Susquehanna
Susquehanna Maintains Negative on RXO, Lowers Price Target to $12
RXO Price Target Maintained With a $33.00/Share by Citigroup
A Quick Look at Today's Ratings for RXO Inc(RXO.US), With a Forecast Between $12 to $33
Express News | RXO Inc : Citigroup Cuts to Neutral From Buy
Sentiment Still Eluding RXO, Inc. (NYSE:RXO)
RXO Analyst Ratings
Wells Fargo Initiates RXO Inc(RXO.US) With Hold Rating, Announces Target Price $31
Barclays Maintains RXO Inc(RXO.US) With Buy Rating, Maintains Target Price $32
A Quick Look at Today's Ratings for RXO Inc(RXO.US), With a Forecast Between $25 to $31
BofA Securities Maintains RXO Inc(RXO.US) With Hold Rating, Maintains Target Price $30
RXO Inc (RXO) Q3 2024 Earnings Call Highlights: Strategic Moves and Market Challenges